参考文献/References:
[1]赵鹤,魏晓敏,尹素凤.1988-2017年中国居民胃癌死亡趋势分析[J].实用预防医学,2020,27(12):1468-1471.[2]韩方征,张潇霖,董唯一,等.肿瘤干细胞标志物CD24、CD44在胃癌组织中的共表达及患者临床病理参数和预后[J].中国组织工程研究,2018,22(29):4625-4630.[3]Dai ZT,Xiang Y,Duan YY.MiR-17-5p and MKL-1 modulate stem cell characteristics of gastric cancer cells[J].Int J Biol Sci,2021,17(9):2278-2293.[4]Walcher L,Kistenmacher AK,Suo H.Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies[J].Front Immunol,2020,11:1280. [5]Takaishi S,Okumura T,Tu S,et al.Identification of gastric cancer stem cells using the cell surface marker CD44[J].Stem Cells,2009,27(5):1006-1020.[6]Dzobo K,Sinkala M.Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial-Mesenchymal Transition, and Metastasis[J].OMICS,2021,25(5):313-332. [7]毛苇,陶力,赵心恺,等.抑癌基因GKN2在胃癌中的表达及其临床意义[J].新医学,2018,49(7):489-492.[8]戴劲,彭铁立,余相地.过表达胃动蛋白对胃癌细胞生物行为学的影响[J].消化肿瘤杂志(电子版),2020,12(2):117-121.[9]Zhang Z,Xue H,Dong Y,et al.GKN2 promotes oxidative stress-induced gastric cancer cell apoptosis via the Hsc70 pathway[J].J Exp Clin Cancer Res,2019,38(1):338. [10]Sun L,Huang C,Zhu M,et al.Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis[J].Theranostics,2020,10(26):11950-11962. [11]Fatehullah A,Terakado Y,Sagiraju S.A tumour-resident Lgr5+ stem-cell-like pool drives the establishment and progression of advanced gastric cancers[J].Nat Cell Biol,2021,23(12):1299-1313.[12]Ni H,Qin H,Sun C.MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis[J].Stem Cell Res Ther,2021,12(1):325.[13]Yang F,Zheng Z,Xue X,et al.Targeted eradication of gastric cancer stem cells by CD44 targeting USP22 small interfering RNA-loaded nanoliposomes[J].Future Oncol,2019,15(3):281-295.[14]Chung Nien Chin S,O’Connor L,Scurr M,et al.Coordinate expression loss of GKN1 and GKN2 in gastric cancer via impairment of a glucocorticoid-responsive enhancer[J].Am J Physiol Gastrointest Liver Physiol,2020,319(2):G175-G188.[15]蔡志宏,曹怡静,刘姣,等.转染胃动蛋白2基因抑制人胃癌细胞系MKN28增殖、迁移和侵袭[J].基础医学与临床,2018,38(3):370-374.[16]Zhang H,Wang M,He Y,et al.Chemotoxicity-induced exosomal lncFERO regulates ferroptosis and stemness in gastric cancer stem cells[J].Cell Death Dis,2021,12(12):1116. [17]Li H,Wang C,Lan L,et al.METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability[J].Cell Mol Life Sci,2022,79(3):135. [18]Lee JH,Kim S,Han S,et al.p57Kip2 imposes the reserve stem cell state of gastric chief cells[J].Cell Stem Cell,2022,29(5):826-839.[19]Ukai S,Honma R,Sakamoto N,et al.Molecular biological analysis of 5-FU-resistant gastric cancer organoids; KHDRBS3 contributes to the attainment of features of cancer stem cell[J].Oncogene,2020,39(50):7265-7278. [20]Kim O,Yoon JH,Choi WS,et al.Heterodimeric interaction between GKN2 and TFF1 entails synergistic antiproliferative and pro-apoptotic effects on gastric cancer cells[J].Gastric Cancer,2017,20(5):772-783.[21]Liu W,Li J,Zhang D,et al.Trefoil factor 1 and gastrokine 2 inhibit Helicobacter pylori-induced proliferation and inflammation in gastric cardia and distal carcinogenesis[J].Oncol Lett,2020,20(6):318.
相似文献/References:
[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Journal of Medical Information,2018,31(01):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Journal of Medical Information,2018,31(01):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Journal of Medical Information,2018,31(01):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Journal of Medical Information,2018,31(01):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(01):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[6]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Journal of Medical Information,2018,31(01):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[7]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Journal of Medical Information,2018,31(01):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[8]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Journal of Medical Information,2018,31(01):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[9]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(01):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[10]牛 悦,白建平,卢建跃.HER-2阳性胃癌的研究进展[J].医学信息,2019,32(01):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
NIU Yue,BAI Jian-ping,LU Jian-yue.Progress in Research of HER-2 Positive Gastric Cancer[J].Journal of Medical Information,2019,32(01):44.[doi:10.3969/j.issn.1006-1959.2019.01.015]
[11]任 芳,陈毅德,冯丽华,等.胃癌细胞系中CD44+胃癌干细胞的表达和意义[J].医学信息,2020,33(20):45.[doi:10.3969/j.issn.1006-1959.2020.20.013]
REN Fang,CHEN Yi-de,FENG Li-hua,et al.Expression and Significance of CD44+ Gastric Cancer Stem Cells in Gastric Cancer Cell Lines[J].Journal of Medical Information,2020,33(01):45.[doi:10.3969/j.issn.1006-1959.2020.20.013]